SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
Mike
Lv5
820 积分
2023-09-06 加入
最近求助
最近应助
互助留言
Drug repurposing and structure-based discovery of new PDE4 and PDE5 inhibitors
19天前
已完结
Intra- and Interspecies Reactivity of Human and Mouse Natural Killer (NK) Cells
29天前
已关闭
Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer
1个月前
已关闭
Correlations of response rate and progression-free survival with overall survival in immunotherapy trials for metastatic non-small-cell lung cancer: an FDA pooled analysis
1个月前
已完结
ATG-101 is a tetravalent PD-L1×4-1BB bispecific antibody that stimulates anti-tumor immunity through PD-L1 blockade and PD-L1-directed 4-1BB activation
1个月前
已完结
Multi-modal molecular determinants of clinically relevant osteoporosis subtypes
1个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
Safety of Fibroblast Activation Protein–Targeted Radionuclide Therapy by a Low-Dose Dosimetric Approach Using 177Lu-FAPI04
1个月前
已完结
Synthesis and Preliminary Evaluation of 131I-Labeled FAPI Tracers for Cancer Theranostics
1个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
2个月前
已完结
Antiganglioside antibody frequency in routine clinical care settings
25天前
已采纳
速度真快
19天前
不需要了【积分已退回】
29天前
已下载到了【积分已退回】
1个月前
点赞,点赞
1个月前
帮大忙了
1个月前
速度真快
1个月前
速度真快
1个月前
帮大忙了
1个月前
速度真快
1个月前
速度真快
2个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论